Lydian Neurosciences

Lydian Neurosciences was a private biotechnology company focused on developing small-molecule therapies for sleep disorders. The company appears to have been created within the Accelerator Life Science Partners venture-creation ecosystem and was based in Seattle, Washington. Publicly available descriptions of the business are sparse, and no named drug candidates, molecular targets, or clinical-stage assets were identified in accessible sources. Company databases indicate it raised an early pre-seed round and was later marked as permanently closed. Overall, Lydian Neurosciences appears to have been an early-stage neuroscience startup that did not advance into publicly visible clinical development.